Skip to content
★ Sign in to follow
NM

Natalie McClure

Executive
Adamas Pharmaceuticals Inc
Total declarations
21
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€1.0M

Latest filing published 20 Apr 2016 for Adamas Pharmaceuticals Inc, €20k.

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Natalie McClure: trading record in brief

Natalie McClure is a declared insider of Adamas Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 21 filings; the first trade dates from 1 December 2014 and the latest from 18 April 2016.

No open-market purchase appears, only 10 sales worth €1.0M. Other entries cover 1 share grant and 10 option exercises. So far in 2016, the count stands at no purchases and 2 sales.

The latest filing, published on 20 April 2016, reports an option exercise of €20k in Adamas Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Natalie McClure

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations